Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

2.15
Delayed Data
As of Feb 21
 -0.02 / -0.92%
Today’s Change
1.20
Today|||52-Week Range
8.22
+38.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Anzalone Christopher Richard
Chief Executive Officer
Sale12/13/2016300,444$1.27$381.6K+69.29%
Myszkowski Kenneth Allen
Chief Financial Officer
Sale8/22/201613,100$8.00$104.8K-72.26%
Given Douglass B
Director
Sale10/14/201612,000$6.72$80.6K-67.62%
Anzalone Christopher Richard
Chief Executive Officer
Buy6/30/201615,772$5.09$80.3K-59.59%
Myszkowski Kenneth Allen
Chief Financial Officer
Sale8/23/20166,900$8.00$55.2K-73.39%
Myszkowski Kenneth Allen
Chief Financial Officer
Buy8/22/201613,100$2.01$26.3K-72.26%
Myszkowski Kenneth Allen
Chief Financial Officer
Buy8/23/20166,900$2.01$13.9K-73.39%
Ferrari Mauro
Director
Gift6/13/20168,517$0.00$0.00-63.37%
Given Bruce D
Chief Operating Officer
Gift1/01/2017380,000$0.00$0.00+27.98%
Myszkowski Kenneth Allen
Chief Financial Officer
Gift1/01/2017145,000$0.00$0.00+27.98%
Page of 2